osimertinib
astrazeneca
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'lung', 'osimertinib']
 doing a masterful job dissecting the results of phase 2 trial neoadjuvant osimertinib in egfr mutated nsclc. take home : you have to find lung cancer early on to treat. #asco23 #lcsm 
Hem/Onc fellow at @karmanoscancer. Alum @AlbanyMed
 @mcgillu. AΩA. GI Oncology Mednet Associate Editor.